Amedeo Smart

Free Medical Literature Service


 

Amedeo

Otorhinolaryngology

  Free Subscription

Articles published in
Cancer
    October 2021
  1. TREISTER NS, Brennan MT, Sollecito TP, Schmidt BL, et al
    Exposed bone in patients with head and neck cancer treated with radiation therapy: An analysis of the Observational Study of Dental Outcomes in Head and Neck Cancer Patients (OraRad).
    Cancer. 2021 Oct 19. doi: 10.1002/cncr.33948.
    >> Share

  2. REN J, Pang W, Hueniken K, Haddad G, et al
    Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
    Cancer. 2021 Oct 1. doi: 10.1002/cncr.33936.
    >> Share

    September 2021
  3. FOSTER CC, Couey MA, Kochanny SE, Khattri A, et al
    Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors.
    Cancer. 2021 Sep 21. doi: 10.1002/cncr.33780.
    >> Share

  4. MEIJER AJM, Li KH, Brooks B, Clemens E, et al
    The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments.
    Cancer. 2021 Sep 7. doi: 10.1002/cncr.33848.
    >> Share

  5. BROCK PR
    New insights into cisplatin ototoxicity.
    Cancer. 2021 Sep 7. doi: 10.1002/cncr.33847.
    >> Share

    August 2021
  6. SEAMAN AT, Seligman KL, Nguyen KK, Al-Qurayshi Z, et al
    Characterizing head and neck cancer survivors' discontinuation of survivorship care.
    Cancer. 2021 Aug 30. doi: 10.1002/cncr.33888.
    >> Share

  7. HARDMAN JC, Tikka T, Paleri V
    Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study.
    Cancer. 2021 Aug 19. doi: 10.1002/cncr.33800.
    >> Share

  8. CHERA BS, Sheth SH, Patel SA, Goldin D, et al
    Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma.
    Cancer. 2021 Aug 11. doi: 10.1002/cncr.33789.
    >> Share

  9. AMIT M, Liu C, Mansour J, Gleber-Netto FO, et al
    Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma.
    Cancer. 2021 Aug 6. doi: 10.1002/cncr.33773.
    >> Share

    July 2021
  10. YU KJ, Hsu WL, Chiang CJ, Chen TC, et al
    Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years.
    Cancer. 2021 Jul 29. doi: 10.1002/cncr.33799.
    >> Share

  11. TRENDOWSKI MR, Baedke JL, Sapkota Y, Travis LB, et al
    Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.
    Cancer. 2021 Jul 19. doi: 10.1002/cncr.33775.
    >> Share

  12. LIU Z, Li H, Yu KJ, Xie SH, et al
    Comparison of new magnetic resonance imaging grading system with conventional endoscopy for the early detection of nasopharyngeal carcinoma.
    Cancer. 2021 Jul 7. doi: 10.1002/cncr.33552.
    >> Share

    June 2021
  13. WITHROW DR, Devesa SS, Deapen D, Petkov V, et al
    Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004-2017.
    Cancer. 2021 Jun 23. doi: 10.1002/cncr.33553.
    >> Share

  14. FU TS, Scheffler P, Forner D, Noel CW, et al
    A cost-utility analysis comparing CT surveillance, PET-CT surveillance, and planned postradiation neck dissection for advanced nodal HPV-positive oropharyngeal cancer.
    Cancer. 2021 Jun 1. doi: 10.1002/cncr.33653.
    >> Share

    May 2021
  15. RUAN X, Liang JH, Pan Y, Cai R, et al
    Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single-arm, prospective phase 2 study.
    Cancer. 2021 May 27. doi: 10.1002/cncr.33626.
    >> Share

  16. XIAO C, Beitler JJ, Peng G, Levine ME, et al
    Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study.
    Cancer. 2021 May 24. doi: 10.1002/cncr.33641.
    >> Share

  17. WEISS JM
    Surgery alone for transorally resected human papillomavirus-driven head and neck cancer-Can we de-intensify adjuvant therapy to 0 Gy and 0 mg/m(2) ?
    Cancer. 2021 May 6. doi: 10.1002/cncr.33610.
    >> Share

    April 2021
  18. DAHLSTROM KR, Song J, Thall PF, Fuller CD, et al
    Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis.
    Cancer. 2021;127:1228-1237.
    >> Share

  19. CHEN Y, Chang ET, Liu Q, Cai Y, et al
    Occupational exposures and risk of nasopharyngeal carcinoma in a high-risk area: A population-based case-control study.
    Cancer. 2021 Apr 6. doi: 10.1002/cncr.33536.
    >> Share

  20. THOMAS GR
    Racial disparity in head and neck cancer.
    Cancer. 2021 Apr 2. doi: 10.1002/cncr.33555.
    >> Share

  21. VOORA RS, Kotha NV, Kumar A, Qiao EM, et al
    Association of Race and Health Care System With Disease Stage and Survival in Veterans With Larynx Cancer.
    Cancer. 2021 Apr 2. doi: 10.1002/cncr.33557.
    >> Share

  22. DRAKE VE, Fakhry C, Windon MJ, Stewart CM, et al
    Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
    Cancer. 2021;127:1029-1038.
    >> Share

    March 2021
  23. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    >> Share

    February 2021
  24. DE BREE R, de Keizer B
    Comparison of different diagnostic approaches in the management of the clinically negative neck in early oral cancer patients.
    Cancer. 2021 Feb 26. doi: 10.1002/cncr.33443.
    >> Share

  25. NOEL CW, Forner D, Goldstein DP, Metser U, et al
    Elective neck dissection versus positron emission tomography-computed tomography-guided management of the neck in clinically node-negative early oral cavity cancer: A cost-utility analysis.
    Cancer. 2021 Feb 26. doi: 10.1002/cncr.33446.
    >> Share

  26. KIONG KL, Yao CMKL, Lin FY, Bell D, et al
    Delay to surgery after neoadjuvant chemotherapy in head and neck squamous cell carcinoma affects oncologic outcomes.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33471.
    >> Share

  27. SHEWALE JB, Pickard RKL, Xiao W, Jiang B, et al
    Independent association of marijuana use and poor oral hygiene with HPV-negative but not HPV-positive head and neck squamous cell carcinomas.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33440.
    >> Share

  28. WANG SM, Freedman ND, Katki HA, Matthews C, et al
    Gastroesophageal reflux disease: A risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the NIH-AARP Diet and Health Study cohort.
    Cancer. 2021 Feb 22. doi: 10.1002/cncr.33427.
    >> Share

  29. LYDIATT WM
    Head and neck cancer staging: Balancing innovation with consistency.
    Cancer. 2021 Feb 17. doi: 10.1002/cncr.33415.
    >> Share

  30. PRINTZ C
    Study adds evidence to link between gum disease and cancer risk: Researchers observe connection with gastric, esophageal cancer.
    Cancer. 2021;127:495-496.
    >> Share

    January 2021
  31. YAO CMKL, Fu S, Tam S, Kiong KL, et al
    Impact of provider type and number of providers on surveillance testing among survivors of head and neck cancers.
    Cancer. 2021 Jan 20. doi: 10.1002/cncr.33402.
    >> Share

  32. LIN YT, Wang HC, Tsai MH, Su YY, et al
    Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma.
    Cancer. 2021 Jan 6. doi: 10.1002/cncr.33391.
    >> Share

    December 2020

  33. Head and neck cancer surgery during the COVID-19 pandemic: An international, multicenter, observational cohort study.
    Cancer. 2020 Dec 21. doi: 10.1002/cncr.33320.
    >> Share

  34. AMIT M, Liu C, Gleber-Netto FO, Kini S, et al
    Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck.
    Cancer. 2020 Dec 15. doi: 10.1002/cncr.33373.
    >> Share

    November 2020
  35. KAWASAKI M, Ikeda Y, Ikeda E, Takahashi M, et al
    Oral infectious bacteria in dental plaque and saliva as risk factors in patients with esophageal cancer.
    Cancer. 2020 Nov 6. doi: 10.1002/cncr.33316.
    >> Share

    October 2020
  36. MORGAN RL, Eguchi MM, McDermott J, Mueller AC, et al
    Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer.
    Cancer. 2020 Oct 29. doi: 10.1002/cncr.33244.
    >> Share

  37. LIU W, Qdaisat A, Ferrarotto R, Fuller CD, et al
    Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation.
    Cancer. 2020 Oct 21. doi: 10.1002/cncr.33283.
    >> Share

  38. SWIECICKI PL, Bellile EL, Brummel CV, Brenner JC, et al
    Efficacy of axitinib in metastatic head and neck cancer with novel radiographic response criteria.
    Cancer. 2020 Oct 20. doi: 10.1002/cncr.33226.
    >> Share

  39. ZHANG N, Li Y, Chang X, Lei F, et al
    Long-term effectiveness of one-time endoscopic screening for esophageal cancer: A community-based study in rural China.
    Cancer. 2020;126:4511-4520.
    >> Share

  40. ZAKERI K, Rotolo F, Lacas B, Vitzthum LK, et al
    Predictive classifier for intensive treatment of head and neck cancer.
    Cancer. 2020 Oct 5. doi: 10.1002/cncr.33212.
    >> Share

    June 2020
  41. BROUGHMAN JR, Xiong DD, Moeller BJ, Contrera KJ, et al
    Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis.
    Cancer. 2020;126:2784-2790.
    >> Share

  42. LANG KUHS KA, Wood CB, Wiggleton J, Aulino JM, et al
    Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer.
    Cancer. 2020;126:2658-2665.
    >> Share

    April 2020
  43. BIGELOW EO, Blackford AL, Eytan DF, Eisele DW, et al
    Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls.
    Cancer. 2020;126:1793-1803.
    >> Share

  44. FULLERTON ZH, Butler SS, Mahal BA, Muralidhar V, et al
    Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status.
    Cancer. 2020;126:1424-1433.
    >> Share

  45. OLIVER JR, Lieberman SM, Tam MM, Liu CZ, et al
    Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma.
    Cancer. 2020;126:1413-1423.
    >> Share

    March 2020
  46. WILSON CL, Brinkman TM, Cook C, Huang S, et al
    Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime Cohort.
    Cancer. 2020;126:1330-1338.
    >> Share

  47. ZHAN KY, Puram SV, Li MM, Silverman DA, et al
    National treatment trends in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2020;126:1295-1305.
    >> Share

    January 2020
  48. FREITAG J, Wald T, Kuhnt T, Gradistanac T, et al
    Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2020;126:1856-1872.
    >> Share

  49. RODEN DF, Hobelmann K, Vimawala S, Richa T, et al
    Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
    Cancer. 2020;126:1873-1887.
    >> Share

  50. FAN M, Kang JJ, Lee A, Fan D, et al
    Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.
    Cancer. 2020;126:1905-1916.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016